Monday, June 16th, 2025

Master card (MA.NYSE):$502.26, break resistance.

“Master card (MA.NYSE):$502.26, break resistance.”
TP1:$510.93
TP2:$520.06
SL:$483.54

Mastercard (NYSE: MA) is a global leader in payment processing technologies. It provides services such as credit, debit, and prepaid card transactions, along with secure payment solutions for businesses and consumers worldwide. Mastercard has consistently maintained its position as a top player in the fintech industry, driven by the rise of digital payments and a shift towards a cashless economy.

As of October 2024, Mastercard’s stock price recently hit $502.26, breaking through a key resistance level, indicating strong market momentum. This follows a series of positive earnings reports. For Q2 2024, Mastercard reported earnings per share (EPS) of $3.59, surpassing analysts’ expectations of $3.51. Its revenue also came in strong at $6.96 billion, beating the forecast of $6.85 billion. This represents an 11% year-over-year revenue growth, reflecting Mastercard’s ability to capture more business globally as digital payments continue to expand.

The company’s next earnings report, expected on October 24, 2024, is anticipated to further reflect strong performance, with EPS estimates at $3.73 and revenue projected at $7.3 billion. Mastercard’s strategic moves, such as partnerships for cross-border payments and innovations in digital payments, continue to solidify its market position. Analysts generally maintain a bullish outlook on the stock, citing its steady growth and robust fundamentals, despite a high price-to-earnings (P/E) ratio of around 30x

Thank you

Wilmar International: A Strategic Look

Wilmar International: Current Price: S$3.12 Target Price: S$3.33 Stop-Loss Price: S$3.06 Recommendation: Trading Buy Investment Thesis: Wilmar International is trading in a bullish trend, with both MACD lines above zero. The stock price has...

Sino Biopharmaceutical Ltd Positioned for Strong Gains with Technical Buy Momentum

Date: September 17, 2024Broker: CGS-CIMB Securities Company Overview Sino Biopharmaceutical Ltd (Stock Code: 1177) is a major pharmaceutical company based in Hong Kong. It focuses on the research, development, production, and distribution of biopharmaceutical...

Asia Pacific Market Outlook: Key Indices Analysis and Technical Trends for February 2025

Comprehensive Analysis of APAC and Global Indices – February 10, 2025 Comprehensive Analysis of APAC and Global Indices Broker: CGS-CIMB | Date: February 10, 2025 Nikkei 225 Index: Tight Consolidation with Bullish Hints The...